Clinical trial
Lobradimil and Carboplatin in Treating Children With Brain Tumors
NCT00019422 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019422 |
|---|---|
| Title | Lobradimil and Carboplatin in Treating Children With Brain Tumors |
| Official title | A Phase II Trial of Intravenous Cereport (RMP-7) and Carboplatin in Childhood Brain Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Children's Oncology Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | carboplatin, lobradimil |
| Start date | Mar 1, 1998 |
| Completion | Apr 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 16, 2013 |
| Countries | Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: